Eyenovia to Present at Upcoming H.C. Wainwright 3rd Annual Ophthalmology Virtual Conference

<p>NEW YORK, Aug. 09, 2023 (GLOBE NEWSWIRE) — Eyenovia, Inc. (Nasdaq: EYEN), an ophthalmic technology company commercializing Mydcombi™ (tropicamide and phenylephrine hydrochloride ophthalmic spray) 1%/2.5% for mydriasis and developing the Optejet® device for use both in connection with its own drug-device therapeutic product candidates for presbyopia and pediatric progressive myopia as well as out-licensing for […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/eyenovia-to-present-at-upcoming-h-c-wainwright-3rd-annual-ophthalmology-virtual-conference/">Eyenovia to Present at Upcoming H.C. Wainwright 3rd Annual Ophthalmology Virtual Conference</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>